Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Helius Medical Technologies, Inc.

< Previous 1 2 Next >
Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
University of Montreal’s School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. Compliant with All Applicable Nasdaq Listing Criteria
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies Announces Reverse Stock Split
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. Reports Second Quarter 2023 Financial Results
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. Announces Participation of Montefiore Medical Center in its PoNS® Therapeutic Experience Program
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. to Release Second Quarter 2023 Financial Results on August 10, 2023
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. Expands Stroke Trial at the Medical University of South Carolina
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies Announces DMEPOS Accreditation for PoNS
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius to Highlight Innovative PoNS Therapy™ at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting, in Commemoration of World MS Day
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. Reports First Quarter 2023 Financial Results
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. to Release First Quarter 2023 Financial Results on May 11, 2023
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Class A Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to Mild and Moderate Symptoms from Stroke
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies to Present at the 35th Annual ROTH Conference
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies to Showcase PoNS Therapy™ at American Physical Therapy Association’s 2023 Combined Sections Meeting
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies to Present at the Virtual Q1 Investor Summit Microcap Event, January 26, 2023
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Tickers HSDT
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.